Correspondence 0001437749-24-027979 from BioCardia, Inc. (BCDA)
BioCardia, Inc.
Date: Aug. 29, 2024 · CIK: 0000925741 · Accession: 0001437749-24-027979
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-281448
Letter
bcda20240828_corresp.htm
August 29, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Daniel Crawford
Re:
BioCardia, Inc.
Registration Statement on Form S-1
File No. 333-281448
Acceleration Request
Requested Date:
August 29, 2024
Requested Time:
4:30 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. hereby requests that its Registration Statement on Form S-1 (File No. 333-281448) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410.
Sincerely,
BIOCARDIA, INC.
Show Raw Text
CORRESP 1 filename1.htm bcda20240828_corresp.htm August 29, 2024 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Daniel Crawford Re: BioCardia, Inc. Registration Statement on Form S-1 File No. 333-281448 Acceleration Request Requested Date: August 29, 2024 Requested Time: 4:30 p.m. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. hereby requests that its Registration Statement on Form S-1 (File No. 333-281448) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410. Sincerely, BIOCARDIA, INC. By: /s/ David McClung David McClung Chief Financial Officer cc: Peter Altman, Ph.D., BioCardia, Inc. Austin D. March, Wilson Sonsini Goodrich & Rosati